The oral administration of Δ9-tetrahydrocannabinol (THC) may treat both spasticity and pain associated with multiple sclerosis. This is according to a study being published by the journal Clinical Therapeutics, and e-published ahead of print by the U.S. National Institute of Health. According to the Mayo Clinic, multiple sclerosis (MS) is a “disease in which the …
Tag: ms cannabis
- clinical therapeutics, Mayo Clinic, ms, ms cannabis, ms marijuana, ms treatment, ms weed, multiple sclerosis, Multiple Sclerosis cannabis, Multiple Sclerosis marijuana, Multiple Sclerosis treatment, Multiple Sclerosis weed, national institute of health, spasticity, Spasticity cannabis, Spasticity marijuana, Spasticity treatment, Spasticity weed
- First-ever First Nation cannabis outdoor grow operation; First Nation cannabis inventor and entrepreneur featured in second edition of “Growth and Prosperity” Magazine
- Wiisag Receives Confirmation of Readiness for Outdoor Cannabis Cultivation
- Arkansas First Ever Medical Marijuana Dispensary Now Open
- Medical Marijuana vs. Recreational Marijuana
- How Does Medicare Cover Arthritis?
- Florida Legislature Approves Bill to Establish Agricultural Hemp Program
- Study: Most Health Professionals (Doctors, Pharmacists and Nurses) Support Medical Marijuana
- Canada: Marijuana Body Gives Recommendations to Boost Industry
Thank you for reading TheJointBlog.com!